Advanced Water Treatment System for On-Site PFAS Capture and Destruction
Project Number1R43ES036038-01
Contact PI/Project LeaderWITT, SUZANNE
Awardee OrganizationENSPIRED SOLUTIONS INC.
Description
Abstract Text
PROJECT SUMMARY
Per- and polyfluorinated alkyl substances (PFAS) comprise a class of thousands of toxic compounds that have
been found in drinking water sources in 34 US states and in the blood of 97% of people tested. Exposure to
PFAS has been linked to immune toxicity, cancer, high cholesterol, and several other health effects. More than
57,000 sites across the US are estimated to have PFAS pollution, and the total remediation market is estimated
at $160 billion. Adsorption technologies are widely used for removing PFAS from water sources, but these
produce secondary waste in the form of PFAS-laden spent sorbent media or complex regenerate solutions.
Disposal or incineration of this secondary waste is costly and becoming highly regulated or even banned in some
states. Enspired Solutions is commercializing a patented PFAS destruction technology called micelle-
accelerated photoactivated reductive defluorination (PRD). We are developing a micelle-accelerated PRD
reactor to degrade PFAS on spent ion exchange (IX) resin and regenerate the resin for further PFAS removal.
The commercial system is the size of two large refrigerators, fully automated and modular to accommodate site-
specific flow rates of 1,000 to 1,000,000 gallons per day of water contaminated with ng/L to µg/L concentrations
of PFAS. Treatment cost estimates are competitive with PFAS capture and disposal. Our proprietary chemical
formulation traps PFAS in solution inside a micelle, where an electron donor generates a hydrated electron upon
exposure to ultraviolet (UV) light. The hydrated electron breaks the carbon-fluorine bonds of PFAS molecules,
which degrades them to environmentally benign by-products. Compared to other PFAS destruction technologies,
micelle-accelerated PRD is more efficient, safer and requires a smaller footprint. When paired with suspended
spent IX resin, the positively charged resin surface can localize PFAS and our electron donor for selective PFAS
destruction. Any PFAS that desorbs from the resin will be captured in a micelle in solution and similarly degraded.
Bench scale micelle-accelerated PRD reactions will be performed on suspensions of IX resin loaded with PFAS
from a synthetic solution. Defluorination of PFAS will be monitored in real time as a function of UV dose and
confirmed with individual PFAS compound analysis. Reaction conditions will be optimized to achieve ≥ 99% (two
orders of magnitude) PFAS destruction. We will test the reusability of the resins after micelle-accelerated PRD
by measuring the adsorption capacity after regeneration, targeting 60 – 80 % capacity retention after each
regeneration cycle. In Phase II, we will test the reaction with a range of real PFAS-laden wastewater samples,
which will have complex matrices and a broader range of PFAS compounds. We will also expand testing to other
media used for PFAS adsorption (ionomers, biochar, modified cornstarch, etc.) and larger sample volumes. This
system will provide a complete, on-site PFAS capture plus destruction solution that will eliminate secondary
waste generation and put an end to the spread of PFAS.
Public Health Relevance Statement
PROJECT NARRATIVE
The widespread contamination of drinking and other water sources with per- and polyfluorinated alkyl substances
(PFAS) represents an urgent public health issue due to adverse health effects associated with PFAS exposure.
The current strategy of removal through adsorption or filtration does not fully address the problem and leads to
further spread of PFAS in the environment. When paired with PFAS capture on adsorbents, the micelle-
accelerated photoactivated reductive defluorination technology developed at Enspired Solutions can provide a
safe, efficient and cost-effective approach for on-site PFAS capture and permanent destruction.
National Institute of Environmental Health Sciences
CFDA Code
143
DUNS Number
118225704
UEI
TG9NQJ5DAVG1
Project Start Date
15-May-2024
Project End Date
30-April-2026
Budget Start Date
15-May-2024
Budget End Date
30-April-2026
Project Funding Information for 2024
Total Funding
$179,465
Direct Costs
$121,964
Indirect Costs
$46,186
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Environmental Health Sciences
$179,465
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R43ES036038-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R43ES036038-01
Patents
No Patents information available for 1R43ES036038-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R43ES036038-01
Clinical Studies
No Clinical Studies information available for 1R43ES036038-01
News and More
Related News Releases
No news release information available for 1R43ES036038-01
History
No Historical information available for 1R43ES036038-01
Similar Projects
No Similar Projects information available for 1R43ES036038-01